Contineum Therapeutics (CTNM) Shares Outstanding (2023 - 2026)

Contineum Therapeutics' Shares Outstanding history runs 4 years deep, the most recent figure standing at $32.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 26.49% year-over-year to $32.7 million; the TTM figure through Mar 2026 stood at $32.7 million (up 26.49% YoY), while the FY2025 annual figure was $31.2 million, up 364.2% from the prior year.
• Shares Outstanding was $32.7 million for Q1 2026 at Contineum Therapeutics, up from $31.2 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $32.7 million in Q1 2026 to a low of $2.3 million in Q1 2023.
• Historically, Shares Outstanding has averaged $16.1 million across 4 years, with a median of $15.9 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding increased 19.49% in 2024, then surged 364.2% in 2025.
• A 4-year view of Shares Outstanding shows it stood at $2.3 million in 2023, then soared by 186.4% to $6.7 million in 2024, then soared by 364.2% to $31.2 million in 2025, then increased by 4.76% to $32.7 million in 2026.
• The last three Shares Outstanding figures came in at $32.7 million (Q1 2026), $31.2 million (Q4 2025), and $22.8 million (Q3 2025), per Business Quant data.